Roche Belgium & Luxembourg
Julie Maes currently serves as the Product Manager for Core Lab - Clinical Indications at Roche Belgium & Luxembourg since December 2024. Prior to this role, Julie was a Product Manager at ArtiQ from September 2019 to December 2024 and held the position of Business Developer for Cardiovascular at Materialise from September 2014 to August 2019, which involved understanding the cardiovascular market and providing global sales and marketing support. Julie's experience also includes time as an Application Engineer and an Engineering Intern at Materialise. Julie holds a Master of Science in Biomedical Engineering from KU Leuven and a Bachelor of Science in Mechanical Engineering from KU Leuven, complemented by studies at EPFL and UCL.
This person is not in the org chart
This person is not in any teams
Roche Belgium & Luxembourg
This page represents both the pharmaceutical and diagnostics divisions of Roche in Belgium, and the pharmaceutical division in Luxembourg. Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people’s lives. The synergy of our divisions has made us the leader in personalised healthcare – a strategy to provide the most effective treatment tailored to each patient. As the world’s largest biotech company, Roche offers differentiated tests and medicines in oncology, immunology, infectious diseases, cardiometabolic diseases, ophthalmology, respiratory disorders and diseases of the central nervous system. We are also the global leader in in vitro diagnostics, tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896 globally and established in 1924 in Belgium, Roche continues to seek better ways to prevent, diagnose, and treat diseases, making a sustainable contribution to society. We work with stakeholders to enhance patient access to medical innovations. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, including life-saving antibiotics, antimalarials, and cancer medicines.Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the fifteenth consecutive year. #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #Innovation For legal information: NL: https://www.roche.be/nl/legal/roche-beLux-social-media-pagina.html FR: https://www.roche.be/fr/legal/reseaux-sociaux-roche-beLux.html